Defibrillator News and Research

Latest Defibrillator News and Research

MRA therapy does not improve outcome in heart attack patients without heart failure

Heart attack patients without heart failure derive no benefit from the addition of mineralocortoid receptor antagonists (MRA), to standard therapy, results of the ALBATROSS study show.

31 Aug 2015

ESC Guidelines recommend DNA analysis for post mortem assessment in young sudden death victims

ESC Guidelines published today recommend DNA analysis as a fundamental component of post mortem assessment in young sudden death victims. Identification of a genetic cause helps to quickly diagnose and protect relatives.

29 Aug 2015

Boston Scientific receives CE Mark on MRI conditional labeling for CRT-D and ICD systems

Boston Scientific Corporation has received CE Mark on magnetic resonance imaging (MRI) conditional labeling for the current family of EL (Extended Longevity) and MINI implantable cardioverter defibrillator (ICD) and the X4 cardiac resynchronization therapy defibrillator (CRT-D) systems. This revised labeling ensures that future patients and those already implanted with these systems are able to undergo MRI scans if indicated.

25 Aug 2015

CPR123 completes expansion into greater San Antonio, TX area

CPR123 Inc., a leading resource for state-of-the-art emergency response training and AED programs, is pleased to announce that their expansion into the greater San Antonio, TX area has been successfully completed. In addition, CPR123 has also established the CPR123 Foundation which aims to decrease cardiac arrest deaths by providing fully-funded and accessible CPR training, equipment, and healthy hearts workshops.

24 Aug 2015

One in four people with implanted defibrillators experiences improvements in heart function

A Johns Hopkins-led study of outcomes among 1,200 people with implanted defibrillators -- devices intended to prevent sudden cardiac death from abnormal heart rhythms -- shows that within a few years of implantation, one in four experienced improvements in heart function substantial enough to put them over the clinical threshold that qualified them to get a defibrillator in the first place.

28 Jul 2015

Study: Around 6% survive cardiac arrest outside of hospital setting

Cardiac arrest strikes almost 600,000 people each year, killing the vast majority of those individuals, says a new report from the Institute of Medicine. Every year in the U.S., approximately 395,000 cases of cardiac arrest occur outside of a hospital setting, in which less than 6 percent survive. Approximately 200,000 cardiac arrests occur each year in hospitals, and 24 percent of those patients survive. Estimates suggest that cardiac arrest is the third leading cause of death in the U.S. behind cancer and heart disease.

1 Jul 2015

Life-saving defibrillators are grossly underutilized, shows study

Heart attack patients age 65 and older who have reduced heart function might still benefit from implanted defibrillators, according to a Duke Medicine study published in the Journal of the American Medical Association.

24 Jun 2015

UCSF researchers propose systematic methods to determine causes of death in patients with CIEDs

The current monitoring of patients with cardiac implantable electronic devices (CIEDs) such as pacemakers and defibrillators may be underestimating device problems, according to UC San Francisco researchers who propose systematic methods to determine accurate causes of sudden death in those with CIEDs as well as improved monitoring for device concerns.

23 Jun 2015

Cardiac device wearers ought to keep safe distance from smartphones to prevent unwanted painful shocks

Cardiac device wearers should keep a safe distance from smartphones to avoid unwanted painful shocks or pauses in function, reveals research presented today at EHRA EUROPACE -- CARDIOSTIM 2015 by Dr. Carsten Lennerz, first author and cardiology resident in the Clinic for Heart and Circulatory Diseases, German Heart Centre, Munich, Germany.

22 Jun 2015

Research reveals how a faulty gene can cause fatal abnormal heart rhythms during exercise

University of Manchester research presented today at the British Cardiovascular Society Conference has revealed how a faulty gene can cause fatal abnormal heart rhythms that are brought on by exercise.

10 Jun 2015

CVRx announces presentation of positive data from Barostim Therapy for Heart Failure clinical trial at HRS 2015

CVRx, Inc., a private medical device company, announced that positive results from the 'Barostim Therapy for Heart Failure' randomized, controlled clinical trial were presented at the 2015 annual Scientific Sessions of the Heart Rhythm Society (HRS) in a Late-Breaking Clinical Trial Session. Results were presented by Dr. Michael Zile from the Medical University of South Carolina.

26 May 2015

Recent CE Mark approvals expand St. Jude Medical’s MRI-compatible device portfolio in Europe

St. Jude Medical, Inc., a global medical device company, today announced CE Mark approval of expanded labelling for its Ellipse implantable cardioverter defibrillator (ICD), in addition to its Durata and Optisure defibrillation leads, allowing existing or future patients with these technologies to undergo magnetic resonance imaging (MRI) scans without compromising device performance.

14 May 2015

Study sheds light on the physical causes of sudden death

Sudden cardiac death accounts for approximately 10% of natural deaths, most of which are due to ventricular fibrillation. Each year it causes 300,000 deaths in the United States and 20,000 in Spain.

17 Apr 2015

Catheter ablation more beneficial to heart failure patients than Amiodarone treatment

Among patients with heart failure and atrial fibrillation, those who underwent catheter ablation were less likely to die, be hospitalized or have recurrent atrial fibrillation than patients taking a heart rhythm regulating drug, according to a study presented at the American College of Cardiology's 64th Annual Scientific Session.

19 Mar 2015

Researchers demonstrate advantages of implanted defibrillator in preventing non-ischaemic heart failure

Sudden cardiac arrest is a possible cause of death in patients with non-ischaemic cardiac muscle weakness, i.e. a type of heart failure caused by genetics or for which no cause is known. Now, researchers at the University Department of Internal Medicine II at the MedUni Vienna (Clinical Department of Cardiology), as part of an international cooperation, have successfully demonstrated the advantages of an implanted defibrillator (ICD) as a means of prevention in patients with moderately restricted cardiac function, and that patients with the condition must be treated as carefully as patients with ischaemic heart failure which has developed following a heart attack, for example.

16 Feb 2015

Boston Scientific announces launch of EL implantable cardioverter defibrillators

Boston Scientific Corporation announces the launch and first U.S. implant of its line of Extended Longevity (EL) implantable cardioverter defibrillators (ICD), including DYNAGEN EL and INOGEN EL device models.

3 Feb 2015

Reducing the risk of sudden cardiac arrest during sports

Time and again, the topic of sudden cardiac death grabs the public's attention when football stars or other top athletes collapse from cardiac arrest in front of the live cameras. This important issue has long been a concern of heart specialists, for cardiac arrest often hits young, apparently healthy and athletic people out of the blue.

11 Dec 2014

Advances in fight against TB, sudden cardiac death

Research projects into two of the biggest killers in worldwide health, tuberculosis and sudden cardiac death, will be the subjects of the University of Leicester Graduate School Doctoral Inaugural Lectures, delivered by two of the winners of this year's PhD prizes in the College of Medicine, Biological Sciences and Engineering.

10 Dec 2014

Implementing risk management practices necessary in health and fitness centers

Health is high on the agenda in many countries with efforts to get more people exercising in order to reduce the problems associated with obesity, such as diabetes, cardiovascular disease and cancer.

3 Dec 2014

St. Jude Medical gets CE Mark approval for updated labeling of Tendril STS, IsoFlex Optim pacing leads

St. Jude Medical, Inc., a global medical device company, today announced CE Mark approval of updated labeling for its Tendril STS and IsoFlex Optim pacing leads, allowing existing and future patients with the devices access to magnetic resonance imaging (MRI) scans.

23 Sep 2014

Defibrillator News and Research

Latest Defibrillator News and Research

MRA therapy does not improve outcome in heart attack patients without heart failure

ESC Guidelines recommend DNA analysis for post mortem assessment in young sudden death victims

Boston Scientific receives CE Mark on MRI conditional labeling for CRT-D and ICD systems

CPR123 completes expansion into greater San Antonio, TX area

One in four people with implanted defibrillators experiences improvements in heart function

Study: Around 6% survive cardiac arrest outside of hospital setting

Life-saving defibrillators are grossly underutilized, shows study

UCSF researchers propose systematic methods to determine causes of death in patients with CIEDs

Cardiac device wearers ought to keep safe distance from smartphones to prevent unwanted painful shocks

Research reveals how a faulty gene can cause fatal abnormal heart rhythms during exercise

CVRx announces presentation of positive data from Barostim Therapy for Heart Failure clinical trial at HRS 2015

Recent CE Mark approvals expand St. Jude Medical’s MRI-compatible device portfolio in Europe

Study sheds light on the physical causes of sudden death

Catheter ablation more beneficial to heart failure patients than Amiodarone treatment

Researchers demonstrate advantages of implanted defibrillator in preventing non-ischaemic heart failure

Boston Scientific announces launch of EL implantable cardioverter defibrillators

Reducing the risk of sudden cardiac arrest during sports

Advances in fight against TB, sudden cardiac death

Implementing risk management practices necessary in health and fitness centers

St. Jude Medical gets CE Mark approval for updated labeling of Tendril STS, IsoFlex Optim pacing leads

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Defibrillator News and Research

Latest Defibrillator News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in